Objective Sodium–glucose cotransporter 2 (SGLT-2) inhibitors are the most recently approved antihyperglycemic medications. We sought to describe their association with euglycemic diabetic ...

Patients with diabetes who take semaglutide are at increased risk for NAION compared with patients who do not use GLP-1 RAs to control their blood sugar, a new study finds.

Indications and Important Safety Information Gvoke is an antihypoglycemic agent indicated ... Concomitant use of anticholinergic drugs with Gvoke VialDx is not recommended. Monitor blood glucose ...

Indications and Important Safety Information Gvoke is an antihypoglycemic agent indicated for subcutaneous use for the treatment of severe hypoglycemia in adult and pediatric patients aged 2 years ...